At close: December 11 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,501.9460
18,136.8800
13,444.5420
5,927.1990
2,383.7040
Cost of Revenue
8,667.3460
11,564.3860
8,577.4870
4,439.4780
1,388.6260
Gross Profit
5,834.6000
6,572.4940
4,867.0550
1,487.7210
995.0780
Operating Expense
7,095.3850
10,547.1520
8,041.9800
4,500.7070
6,869.7200
Operating Income
-1,260.7850
-3,974.6580
-3,174.9250
-3,012.9860
-5,874.6420
Net Non Operating Interest Income Expense
-2,388.4040
-2,575.1350
-2,800.5150
-1,311.8170
-748.7780
Other Income Expense
-635.8170
-344.6170
-3,300.1880
-4,102.3480
-804.2650
Pretax Income
-4,285.0060
-6,894.4100
-9,275.6280
-8,427.1510
-7,427.6850
Tax Provision
1,092.8430
187.8480
204.9170
--
--
Net Income Common Stockholders
-5,395.5490
-7,099.9580
-9,563.5670
-8,869.3790
-8,510.1860
Diluted NI Available to Com Stockholders
-5,395.5490
-7,099.9580
-9,563.5670
-8,869.3790
-8,510.1860
Basic EPS
-0.05
-0.06
-0.10
-0.13
-0.17
Diluted EPS
-0.05
-0.06
-0.10
-0.13
-0.17
Basic Average Shares
109,758.6560
117,196.8360
97,166.6070
69,537.7310
50,895.3010
Diluted Average Shares
109,758.6560
117,196.8360
97,166.6070
69,537.7310
50,895.3010
Total Operating Income as Reported
-1,260.7850
-3,974.6580
-3,174.9250
-3,012.9860
-5,874.6420
Total Expenses
15,762.7310
22,111.5380
16,619.4670
8,940.1850
8,258.3460
Net Income from Continuing & Discontinued Operation
-5,377.8490
-7,082.2580
-9,475.0670
-8,869.3790
-7,679.6920
Normalized Income
-4,875.5536
-6,101.6334
-6,879.7607
-4,193.2910
-6,525.4720
Interest Expense
2,388.4040
2,575.1350
2,800.5150
1,311.8170
748.7780
Net Interest Income
-2,388.4040
-2,575.1350
-2,800.5150
-1,311.8170
-748.7780
EBIT
-1,896.6020
-4,319.2750
-6,475.1130
-7,115.3340
-6,678.9070
EBITDA
618.9400
-1,637.9450
-5,369.3840
-6,603.4010
-6,461.2720
Reconciled Cost of Revenue
6,777.9230
9,757.4680
7,803.1340
4,428.1190
1,370.6740
Reconciled Depreciation
2,515.5420
2,681.3300
1,105.7290
511.9330
217.6350
Net Income from Continuing Operation Net Minority Interest
-5,377.8490
-7,082.2580
-9,480.5450
-8,427.1510
-7,427.6850
Total Unusual Items Excluding Goodwill
-635.8170
-1,241.2970
-3,292.1320
-4,233.8600
-902.2130
Total Unusual Items
-635.8170
-1,241.2970
-3,292.1320
-4,233.8600
-902.2130
Normalized EBITDA
1,254.7570
-396.6480
-2,077.2520
-2,369.5410
-5,559.0590
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
--
Tax Effect of Unusual Items
-133.5216
-260.6724
-691.3477
--
--
12/31/2020 - 3/1/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BUDZ WEED, Inc.
0.0400
+7.82%
ERBB American Green, Inc.
0.0007
0.00%
ATTBF Abattis Bioceuticals Corp.
0.0001
0.00%
HEMP Hemp, Inc
0.0000
0.00%
EDXC Endexx Corporation
0.0100
0.00%
BLMH Blum Holdings, Inc.
0.4800
-3.96%
MJNA Medical Marijuana, Inc.
0.0005
+25.00%
PHE.MU Cipher Pharmaceuticals Inc
9.90
0.00%
PHE.SG Cipher Pharmaceuticals Inc
10.00
+2.56%
BSPK Bespoke Extracts, Inc.
0.0807
+32.48%